Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
0.77
0.03 (4.41%)
At close: Aug 15, 2025, 3:54 PM
0.77
-0.62%
After-hours: Aug 15, 2025, 07:38 PM EDT
Virax Biolabs Balance Sheet Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
Cash & Equivalents | 4.23M | 7.29M | 3.59M | 5.11M | 9.35M | 4.57M | 21.76K | 11.68K | 17.62K | n/a |
Short-Term Investments | n/a | 95.55K | 77.32K | 97.56K | 49.26K | n/a | 6K | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 54.5K | 54.5K | n/a |
Other Long-Term Assets | n/a | n/a | -49.77K | -1.05M | -178.4K | n/a | n/a | n/a | n/a | n/a |
Receivables | 30.65K | 2.36K | 217.84K | 183.36K | n/a | n/a | n/a | n/a | 928.00 | n/a |
Inventory | 94.67K | 261.3K | 60.38K | 24.51K | 24.09K | n/a | 20.95K | 21.07K | 21.07K | n/a |
Other Current Assets | n/a | 23.79K | n/a | n/a | n/a | 4.69K | n/a | n/a | n/a | n/a |
Total Current Assets | 4.89M | 8.03M | 4.38M | 5.97M | 9.63M | 5.3M | 48.71K | 43.03K | 39.62K | n/a |
Property-Plant & Equipment | 1.53M | 1.36M | 1.1M | 679.42K | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | 46.19K | 49.77K | 374.67K | 178.4K | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.53M | 1.41M | 1.1M | 1.05M | 178.4K | n/a | n/a | 54.5K | 54.5K | n/a |
Total Assets | 6.43M | 9.44M | 5.48M | 7.03M | 9.81M | 5.3M | 48.71K | 97.53K | 94.12K | n/a |
Account Payables | 56.09K | 118.94K | 45.63K | 408.62K | 159.91K | 427.46K | 846.47K | 236.62K | 217.15K | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | 38.25K | -0.00 | -0.00 | n/a | n/a | n/a |
Short-Term Debt | 32.47K | 222.73K | n/a | n/a | 146.25K | n/a | n/a | 100K | n/a | n/a |
Other Current Liabilities | 60.48K | 114.91K | n/a | n/a | 140.29K | 3.76K | 3.76K | 449.61K | 192K | n/a |
Total Current Liabilities | 673.21K | 693.97K | 168.85K | 787.02K | 908.4K | 1.14M | 1.25M | 1.05M | 871.43K | n/a |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 291.54K | 332.1K | 176.34K | 132.03K | n/a | n/a | n/a | n/a | n/a | n/a |
Total Liabilities | 964.75K | 1.03M | 345.19K | 919.05K | 908.4K | 1.14M | 1.25M | 1.05M | 871.43K | n/a |
Total Debt | 377K | 603.2K | 224.3K | 181.71K | 146.25K | 3.76K | 3.76K | 179.48K | 179.48K | n/a |
Common Stock | 4.34K | 4.34K | 2.57K | 1.81K | 1.56K | 1.17K | 999.00 | 301.00 | 265.00 | n/a |
Retained Earnings | -24.59M | -21.28M | -18.53M | -14.8M | -11.79M | -7.78M | -6.34M | -5.18M | -4.63M | n/a |
Comprehensive Income | 30.28M | 29.93M | 23.89M | 21.13M | 20.92M | 12.17M | 5.36M | 4.44M | 4.03M | n/a |
Shareholders Equity | 5.7M | 8.64M | 5.37M | 6.33M | 9.13M | 4.39M | -974.58K | -744.37K | -596.18K | n/a |
Total Investments | n/a | 95.55K | 77.32K | 97.56K | 49.26K | n/a | 6K | 54.5K | 54.5K | n/a |